Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation

Table 3 CMR characteristics of the study population with AF and controls

Variables	AF patients (n = 80)	Healthy controls (n = 20)	P-value
LAV, mL	122 ± 32	103 ± 11	< 0.001
LVEF, %	62 ± 9	66 ± 7	0.051
LVEDV, mL	123 ± 26	120 ± 27	0.708
LVESV, mL	47 ± 12	41 ± 13	0.027
LV SV, mL	76 ± 16	79 ± 18	0.594
LV mass, g	130 ± 35	122 ± 33	0.118
LV peak SCS (%)	− 18.2 ± 2.0	− 21.9 ± 1.1	< 0.001
LV peak SCS rate (s^− 1)	− 1.15 ± 0.16	− 1.21 ± 0.03	< 0.001
LV early DCS rate (s^− 1)	1.20 ± 0.18	1.35 ± 0.13	< 0.001
LV LGE	0	–	–
LV native T1 time, ms	1280 ± 33	1251 ± 12	< 0.001

Data are expressed as mean ± SD
CMR cardiovascular magnetic resonance, AF atrial fibrillation, LV left ventricle/left ventricular, LAV left atrium volume, LVEF left ventricular ejection fraction, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, SV stroke volume, SCS systolic circumferential strain, DCS diastolic circumferential strain, LGE late gadolinium enhancement

ISSN: 1532-429X